Evidence map›Paper›PMID 41719060›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Jovana Despotović, Neda Nikolić, Tamara Babic, Milena Ugrin, Aleksandra Đikić Rom, Ana Damjanović, Aleksandra Nikolic, Sandra Dragičević

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jovana DespotovićGene Regulation in Cancer Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.ORCID 0000-0003-3098-1965
Neda NikolićClinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.ORCID 0000-0002-0571-2272
Tamara BabicGene Regulation in Cancer Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.ORCID 0000-0001-7117-7944
Milena UgrinRare Disease Research and Therapeutics Development Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Aleksandra Đikić RomDepartment of Pathology, Pathohistology and Medical Cytology, University Clinical Center of Serbia, Belgrade, Serbia.
Ana DamjanovićDepartment for Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
Aleksandra NikolicGene Regulation in Cancer Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.ORCID 0000-0003-3420-3896
Sandra DragičevićGene Regulation in Cancer Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.ORCID 0000-0002-1602-1880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionEarly-onset colorectal cancer (EOCRC) is increasing worldwide, with Serbia showing a similar incidence compared to global trends. Precise mutation genotyping has gained importance following the recent approval of

Indexed as

Colorectal NeoplasmsGTP PhosphohydrolasesMembrane ProteinsProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)AdultAgedAge of OnsetFemaleHumansIncidenceMaleMiddle AgedMutationRetrospective StudiesSerbiaBRAF protein, humanGTP PhosphohydrolasesKRAS protein, humanMembrane ProteinsNRAS protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)BRAFcolorectal cancerearly-onsetKRASNRAS

Identifiers

PMID41719060
PMCPMC12925009

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.